CLDX
Celldex Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+0.36%
vs ±9.8% implied · ×0.04
shaded = implied · ▲▼ = realized
No thesis.
Celldex Therapeutics, Inc.
30.22
Largest filed tie
—
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Wellington Management GroupWellington | $355.1M | 11.13% | +11.49% | |
| 2 | BlackRockBlackRockindex-like | $260.6M | 8.16% | +30.40% | |
| 3 | Kynam Capital ManagementKynam | $198.1M | 6.21% | −8.86% | |
| 4 | T. Rowe Price AssociatesT. Rowe Price | $174.3M | 5.46% | +124.57% | |
| 5 | State StreetState Streetindex-like | $145.1M | 4.55% | +39.09% | |
| 6 | FMRFMR | $138.5M | 4.34% | −0.70% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $128.9M | 4.04% | +17.02% | |
| 8 | Deep Track CapitalDeep Track Capital | $109.4M | 3.43% | +128.91% | |
| 9 | Logos Global ManagementLogos Global | $78.1M | 2.45% | +366.67% | |
| 10 | Geode Capital ManagementGeodeindex-like | $75.3M | 2.36% | +19.79% | |
| 11 | Eversept PartnersEversept Partners | $66.5M | 2.08% | −0.12% | |
| 12 | Goldman Sachs GroupGoldman Sachs | $60.1M | 1.88% | +63.43% | |
| 13 | Commodore CapitalCommodore Capital | $50.2M | 1.57% | −49.94% | |
| 14 | Bellevue GroupBellevue | $44.7M | 1.40% | 0.00% | |
| 15 | Baker Bros. AdvisorsBaker Bros. | $44.0M | 1.38% | +77.74% | |
| 16 | Millennium ManagementMillennium | $43.6M | 1.36% | −6.60% | |
| 17 | Dimensional Fund AdvisorsDimensional | $40.0M | 1.25% | +1.36% | |
| 18 | American Century CompaniesAmerican Century Companies | $38.8M | 1.22% | +21.73% | |
| 19 | Eventide Asset ManagementEventide | $38.6M | 1.21% | 0.00% | |
| 20 | NovoNovo | $38.1M | 1.19% | −14.58% | |
| 21 | Elmind CapitalElmind Capital | $36.8M | 1.15% | +14.45% | |
| 22 | Driehaus Capital ManagementDriehaus | $36.8M | 1.15% | new | |
| 23 | Fisher Asset ManagementFisher | $36.7M | 1.15% | −2.76% | |
| 24 | Pictet Asset Management HoldingPictet | $34.1M | 1.07% | −0.68% | |
| 25 | Foresite Capital Management VIForesite Capital Management VI | $32.7M | 1.03% | +178.47% |
255 managers report $3.2B of Celldex Therapeutics on form 13F for the quarter ended Jun 30 '26. 35 of them hold 80% of it; Wellington is largest at 11.13%.
Expected move
Inputs8Q avg ±3.1%·×2.46·rich
straddle ±10.4%
spot 30.10exp Nov 20ATM strike 30ATM straddle 3.67IV 64%